Skip NavigationSkip to Content

Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis

  1. Author:
    Barozzi, P.
    Potenza, L.
    Riva, G.
    Vallerini, D.
    Quadrelli, C.
    Bosco, R.
    Morselli, M.
    Forghieri, F.
    Volzone, F.
    Rossi, G.
    Ferri, C.
    Bonini, C.
    Ciceri, F.
    Bordignon, C.
    Whitby, D.
    Schulz, T. F.
    Torelli, G.
    Luppi, M.
  2. Author Address

    [Barozzi, Patrizia; Potenza, Leonardo; Riva, Giovanni; Vallerini, Daniela; Quadrelli, Chiara; Bosco, Raffaella; Morselli, Monica; Forghieri, Fabio; Volzone, Francesco; Torelli, Giuseppe; Luppi, Mario] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Azienda Osped Policlin, I-41100 Modena, Italy. [Rossi, Giulio] Univ Modena & Reggio Emilia, Dept Diagnost & Lab Serv & Legal Med, Azienda Osped Policlin, Sect Pathol Anat, I-41100 Modena, Italy. [Ferri, Clodoveo] Univ Modena & Reggio Emilia, Dept Rheumatol, Azienda Osped Policlin, I-41100 Modena, Italy. [Bonini, Chiara; Ciceri, Fabio; Bordignon, Claudio] Ist Sci San Raffaele, Expt Hematol Lab, Canc Immunotherapy & Gene Therapy Program, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy. [Whitby, Denise] NCI, Viral Epidemiol Sect, AIDS Vaccine Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA. [Schulz, Thomas F.] Hannover Med Sch, Inst Virol, D-30623 Hannover, Germany.;Luppi, M, Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Azienda Osped Policlin, Via Pozzo 71, I-41100 Modena, Italy.;mario.luppi@unimore.it
    1. Year: 2009
    2. Date: Dec
  1. Journal: Seminars in Arthritis and Rheumatism
    1. 39
    2. 3
    3. Pages: 170-175
  2. Type of Article: Review
  3. ISSN: 0049-0172
  1. Abstract:

    Objectives: To describe the first in-depth analysis of both the T-cell responses against human herpesvirus-8 (HHV-8) and the HHV-8 viral load in 1 patient who developed iatrogenic HHV-8-associated-Kaposi's sarcoma (KS) following immunosuppressive treatment for undifferentiated arthritis and to review the literature on iatrogenic KS (IKS). Methods: T-cell responses against HHV-8 lytic and latent antigens were analyzed by ex vivo enzyme-linked immunospot (Elispot) and HHV-8 viral load was assessed by quantitative polymerase chain reaction, in sequential peripheral blood samples from a 55-year-old woman who developed skin/mucosal and visceral KS, while receiving treatment with cyclosporine, methotrexate, and methylprednisolone for undifferentiated arthritis. Results: KS may result from HHV-8 infection in patients undergoing immunosuppressive treatment for rheumatic diseases and this is the first case of IKS occurring in undifferentiated arthritis. A role for immune surveillance in the pathogenesis of IKS is supported by the observation of disease regression following discontinuation of immunosuppressive therapy. In a 4-year follow-up, we showed that variations of the virus-specific immune responses but not of the viral load correlated well with the disease course, characterized by 2 remission and subsequent relapse phases, following changes of immunosuppressive therapy. Conclusions: We have provided evidence of a clear-cut correlation between changes in immunologic markers of HHV-8 infection and the disease course of this viral associated tumor, concomitant with variations of immunosuppressive treatment. Thus, ex vivo enzyme-linked immunospot for HHV-8-specific T-cell responses represents a new tool for the clinical management of rheumatic patients with IKS. (C) 2009 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 39:170-175

    See More

External Sources

  1. DOI: 10.1016/j.semarthrit.2008.05.005
  2. WOS: 000277878300004

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel